“CURES-Preparing for the New Duty to Consult Requirements.”

This Weekly’s Hot Topic’s

  • “CURES-Preparing for the New Duty to Consult Requirements,” webinar. (California News)
  • Responses submitted regarding “Blueprint to lower drug prices and reduce out-of-pocket costs.” (National News)
  • CMS has released its proposed rule for 2019 Medicare physician reimbursement. (CMS News)

The California Medical Association, in collaboration with the California Department of Justice and Medical Board of California, will offer a webinar entitled CURES-Preparing for the New Duty to Consult Requirements on August 22 at 12:15 PM. CURES is a database of Schedule II, III, and IV controlled substance prescriptions dispensed in California. Effective October 2, physicians must consult CURES prior to prescribing these medications to a patient for the first time and at least once every four months thereafter if that medication remains part of the patient’s treatment. To read more click here and go to California News.

ASCO, ASH, ACCC, and COA have submitted responses to the Request for Information (RFI) that was included in the Administration’s “blueprint to lower drug prices and reduce out-of-pocket costs”. To read more click here and go to National News.

CMS has released its proposed rule for 2019 Medicare physician reimbursement. CMS estimates that in 2019, overall impact for the hematology/oncology specialty will be a -4% reduction in reimbursement and a -2% reduction for radiation oncology.  To read more click here and go to CMS News.

To read the complete California Oncology Weekly Newsletter, click on the date below.

July 31, 2018

 

This Weekly’s Hot Topic’s

  • The United States Food and Drug Administration has announced a biosimilar action plan. (National News)
  • CMS has released its proposed rule for 2019 Medicare physician reimbursement. (CMS News)

The United States Food and Drug Administration has announced a biosimilar action plan that is meant to spur biosimilar competition by addressing four key areas: improving the efficiency of the biosimilar and interchangeable product development and approval process; maximizing scientific and regulatory clarity for the biosimilar product development community. For more information click here and go to National News.

CMS has released its proposed rule for 2019 Medicare physician reimbursement. CMS estimates that in 2019, overall impact for the hematology/oncology specialty will be a -4% reduction in reimbursement and a -2% reduction for radiation oncology. For more information click here and go to CMS News.

CMS has announced that participants in the Merit-based Incentive Payment System (MIPS) for 2017 can review their MIPS final score and performance feedback onto Quality Payment Program. For more information click here and go to CMS News.

ASCO has opened two Guidelines for comment. The two Guidelines are: Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline and Treatment of Non-Metastatic Colorectal Cancer: ASCO Resource-Stratified Guideline. Both comment periods end July 27.  For more information click here and got to Affiliate Association News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

July 24, 2018

 

This Weekly’s Hot Topic’s

  • Physicians will need to consult California’s prescription drug monitoring database, CURES. (California News)
  • CMS has proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program. (CMS news)

Physicians will need to consult California’s prescription drug monitoring database, CURES, effective October 2. For more information click here and go to California News.

CMS has proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program that would streamline clinical billing and expand access to high-quality care. For more information click here and go to CMS News.

In an effort to provide timely and in-depth examination of critical issues in cancer care, ASCO is pleased to announce the State of Cancer Care in America (SOCCA) series in the Journal of Oncology Practice. For more information click here and go to Affiliate Association News.

To view the complete California Oncology Weekly Newsletter, click on the link below.

July 17, 2018

This Weekly’s Hot Topic’s

  • The National Center for Health Statistics has released the FY 2019 ICD-10-CM code changes. (National News)
  • On July 24 and 26, CMS will host two 60-minute  webinars about public reporting on Physician Compare. (CMS news)

Please join CAPP/MICRA for an evening reception in honor of Assembly Member Marc Berman on Wednesday, August 1st from 4:30 pm – 6:00 pm. The reception will be held at Los Altos Sub-acute and Rehabilitation Center. For more information click here and go to California News.

The National Center for Health Statistics has released the FY 2019 ICD-10-CM code changes. The FY 2019 ICD-10-CM codes are to be used from Oct. 1, 2018 through Sept. 30, 2019. For more information click here and go to National News.

ACCC’s Financial Advocacy Network has published a summary of its Virtual Town Hall covering such topics as coordinating face-to-face meetings with patients, demonstrating the impact of financial navigators, collaborating with specialty pharmacies, staying on top of changes in healthcare laws and coverage, and much more. For more information click here and go to Affiliate Association News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

July 10, 2018

This Weekly’s Hot Topic’s

  • FY 2019 ICD-10-CM code changes have been released. (National News)
  • Send COA any & all PBM delayed & compromised patient care stories. (Affiliate News)
  • BIO opposes any measure shifting greater drug costs to patients. (Industry News)

The National Center for Health Statistics has released the FY 2019 ICD-10-CM code changes. The FY 2019 ICD-10-CM codes are to be used from Oct. 1, 2018 through Sept. 30, 2019. For more information click here and go to National News.

Physicians who bill Medicare for telehealth services are reminded that they must use the place of service code 02 to indicate services were furnished via telemedicine. Previously, the modifier -GT was used on telehealth claims, but use of this modifier was eliminated except in limited circumstances for certain Critical Access Hospitals billing under Method II. If the -GT modifier is used in any other circumstances, the claim line will be rejected. For more information click here and go to CMS News.

COA and their Pharmacist group, COPA, are needing your help to send to them ANY & ALL PBM delay stories, as well as any other stories where patient care is compromised.  Several fronts, including legislative (federal and state levels) and legal are being tapped into!  The message MUST go out far and wide. Below are some quick links to a couple of projects that COPA board members have been working on. For more information click here and go to Affiliate Association News.

Biotechnology Innovation Organization (BIO) and its members believe that insurance coverage policies should provide all patients access to appropriate treatments in a timely manner. Even seemingly small changes to cost-sharing requirements can have detrimental impacts on patient adherence and can lead to higher health care costs when a disease is not managed appropriately. For more information click here and go to Industry News.

 

To view the complete California Oncology weekly Newsletter, click on the date below.

July 3, 2018